Free Virtual Consultations. Corona Virus Related Cases Click Here.

Child Hospitalized After Crash on Dinah Shore Drive

2 Vehicles Collide in Rollover Accident in Rancho Mirage

Any Type of Accident 4

Rancho Mirage, CA (October 5, 2019) – A car rolled over in Rancho Mirage, causing a child to be sent to the hospital. The accident occurred on the afternoon of October 5 on Dinah Shore Drive.

A Dodge Charger was traveling west on Dinah Shore Drive, near Bob Hope Drive, when the driver lost control. The car rolled over several times and then hit another vehicle.   

A child in the Dodge was taken to a local hospital for observation. The child’s status is unknown.

#Rancho Mirage


February 24, 2020

1 Killed in Pedestrian Crash on San Carlos Street

Driver Hits 2 People in Fatal San Jose Accident...

December 3, 2019

Man Killed When Garbage Truck Crashes on Finch Road

City Employee Crashes Into Tree in Fatal Modesto Accident...

May 13, 2020

Brianna Sanchez Killed, 10 Injured in Crash on Highway 99 Near Mountain View Avenue

6 Vehicles Involved in Fatal Selma Accident...

Free Police Report Request

We offer free consultation. No office visit required, we will get back to you within 24 hours.

  • This field is for validation purposes and should be left unchanged.

What can we do for you?

  • Answer your legal question.
  • Provide a Free Case Evaluation.
  • Schedule an appointment.

Why Choose Us?

  • Available 24/7
  • Trusted Since 1990
  • Local to You
  • Recovered $350,000,000
  • 5 Star Reviews
  • Free Case Evaluation
  • VIP Service
  • No Win, No Fee

Latest Law Post

May 22, 2020

Johnson & Johnson Discontinues Talc-Based Baby Powder

baby powder new Johnson & Johnson discontinued its talc-based baby powders in the United States and Canada because thousands of lawsuits claiming it was contaminated with asbestos created a sales decline.

May 18, 2020

FDA Issues Warnings To Two Manufacturers Of Breast Implants

The U.S. Food and Drug Administration (FDA) just issued warning letters to two manufacturers of breast implants for failing to comply with regulatory requirements. The FDA sent a warning letter to Allergan for failure to comply with requirements to conduct post-approval studies assessing the risks and long-term safety of two separate breast implant models. Both breast implant models were voluntarily recalled last year. The FDA also sent a warning letter to Ideal Implant Incorporated. That letter was sent for failing to comply with adverse event reporting requirements and current good manufacturing practice requirements. The letter was prompted by an inspection which was conducted earlier in 2020.